High-dose insulin to reduce infections after major surgery
Part of Hormones & metabolism, Infections clinical trials.
This trial tests whether giving high-dose insulin around the time of major abdominal surgery can lower the risk of post-surgery infections. If you’re having elective liver, pancreas, or colorectal surgery, the study looks at whether tighter sugar control helps your recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be older than 18 years.
- You’re scheduled for elective (planned) surgery of the liver, pancreas, or colon/rectum.
- You must be able to understand the study and sign consent.
- There are no other inclusion details listed here, but screening may include checks not shown in this excerpt.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if high-dose insulin can help your liver work better and heal faster after a major liver surgery for colorectal cancer that has spread to the liver.
This trial checks if monitoring and treating blood sugar levels during long surgeries can lower the risk of infections and other problems afterward. It is for adults having any surgery expected to last 2 hours or more.
This study tests whether carefully managing blood sugar levels after planned brain surgery can reduce the risk of surgical site infections. Researchers will monitor and control glucose (blood sugar) in the period right after surgery to see if it helps patients heal better.
This trial tests two ways to give insulin after gastrointestinal or vascular surgery to see which one leads to fewer wound infections. It may help if you have type 2 diabetes and are having one of these surgeries.
This study tests whether giving insulin after pancreas surgery helps patients who didn't have diabetes before. The pancreas makes insulin, so removing part of it can affect blood sugar control.
This trial tests a smart insulin pump system (hybrid closed-loop) to control blood sugar in people with type 2 diabetes who need surgery and will receive nutrition through a vein. It aims to prevent high and low blood sugar during and after surgery.
Hear when a new Surgical Site Infection After Major Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.